Trial no.:
|
PACTR201611001683280 |
Date of Approval:
|
14/06/2016 |
Trial Status:
|
Registered in accordance with WHO and ICMJE standards |
|
TRIAL DESCRIPTION |
Public title
|
personalized IVFto maximize success rate |
Official scientific title |
individualized controlled ovarian stimulation for IVF to maximize success rate |
Brief summary describing the background
and objectives of the trial
|
In the last two decades, pregnancy rates for patients undergoing in-vitro fertilization (IVF) have
significantly increased. Some of the major advances responsible for this improvement were the introduction of
controlled ovarian stimulation (COS) for the induction of multiple follicle development, and the utilization of midluteal
gonadotropin-releasing hormone agonists to achieve pituitary down-regulation and full control of the cycle.
As a result, a combination of a gonadotropin-releasing hormone agonist with high doses (150-450 IU/day) of
recombinant follicle-stimulating hormone has become the current standard approach for ovarian stimulation.
However, given the heterogeneity of patients embarking on IVF, and the fact that many different drugs can be
used alone or in different combinations (generating multiple potential protocols of controlled ovarian stimulation),
we consider the need to identify special populations of patients and adapt treatment protocols accordingly, and to
implement a more individualized approach to COS. |
Type of trial |
CCT |
Acronym (If the trial has an acronym then please provide) |
|
Disease(s) or condition(s) being studied |
infertility,Obstetrics and Gynecology |
Sub-Disease(s) or condition(s) being studied |
Fertility-female,Fertility-male |
Purpose of the trial |
Treatment: Other |
Anticipated trial start date |
02/07/2016 |
Actual trial start date |
|
Anticipated date of last follow up |
02/10/2017 |
Actual Last follow-up date |
|
Anticipated target sample size (number of participants) |
500 |
Actual target sample size (number of participants) |
500 |
Recruitment status |
Closed to recruitment,follow-up continuing |
Publication URL |
|
|